Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.
Saved in:
| Title: | Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer. |
|---|---|
| Authors: | Howe GA; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Xiao B; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Zhao H; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Al-Zahrani KN; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Hasim MS; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Villeneuve J; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Surgery, University of Ottawa, Ottawa, ON, Canada., Sekhon HS; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada., Goss GD; Department of Medicine, University of Ottawa, Ottawa, ON, Canada., Sabourin LA; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Dimitroulakos J; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.; Department of Medicine, University of Ottawa, Ottawa, ON, Canada., Addison CL; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.; Department of Medicine, University of Ottawa, Ottawa, ON, Canada. |
| Source: | PloS one [PLoS One] 2016 Mar 10; Vol. 11 (3), pp. e0150567. Date of Electronic Publication: 2016 Mar 10 (Print Publication: 2016). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26962872 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Howe+GA%22">Howe GA</searchLink>; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Xiao+B%22">Xiao B</searchLink>; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Zhao+H%22">Zhao H</searchLink>; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Al-Zahrani+KN%22">Al-Zahrani KN</searchLink>; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Hasim+MS%22">Hasim MS</searchLink>; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Villeneuve+J%22">Villeneuve J</searchLink>; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Surgery, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Sekhon+HS%22">Sekhon HS</searchLink>; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Goss+GD%22">Goss GD</searchLink>; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Sabourin+LA%22">Sabourin LA</searchLink>; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Dimitroulakos+J%22">Dimitroulakos J</searchLink>; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Addison+CL%22">Addison CL</searchLink>; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.; Department of Medicine, University of Ottawa, Ottawa, ON, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2016 Mar 10; Vol. 11 (3), pp. e0150567. <i>Date of Electronic Publication: </i>2016 Mar 10 (<i>Print Publication: </i>2016). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26962872 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0150567 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0150567 Titles: – TitleFull: Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Howe GA – PersonEntity: Name: NameFull: Xiao B – PersonEntity: Name: NameFull: Zhao H – PersonEntity: Name: NameFull: Al-Zahrani KN – PersonEntity: Name: NameFull: Hasim MS – PersonEntity: Name: NameFull: Villeneuve J – PersonEntity: Name: NameFull: Sekhon HS – PersonEntity: Name: NameFull: Goss GD – PersonEntity: Name: NameFull: Sabourin LA – PersonEntity: Name: NameFull: Dimitroulakos J – PersonEntity: Name: NameFull: Addison CL IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 03 Text: 2016 Mar 10 Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 11 – Type: issue Value: 3 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |